Login / Signup

Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemia.

Wenbo JiaXiaodong GuoYihong WeiJinting LiuCan CanRuiqing WangXinyu YangChunyan JiDaoxin Ma
Published in: Molecular biology reports (2023)
could be potential targets for novel treatment in AML.
Keyphrases
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • risk assessment
  • combination therapy
  • acute lymphoblastic leukemia